Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
It is intended strictly for laboratory research use only and is not for human or animal consumption
Wegovy Injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week Alternatively: 1.7 mg subcutaneously once a week Comments: Major adverse cardiovascular (CV) events include CV death, nonfatal myocardial infarction, or nonfatal stroke
Although improved insulin sensitivity was an outcome of this study, this cannot be generalized to a human population due to the use of mice, as well as the lack of whole-body insulin sensitivity measures
Using these pre-filled pens for delivering fractional doses is quite challenging
Fewer-than-four ports versus four ports for laparoscopic cholecystectomy
US$ 20.62
US$ 27.94
US$ 26.01
US$ 28.72
US$ 29.25
US$ 24.08
